StockWatch
·
Biotechnology: Pharmaceutical Preparations
AcquisitionsJul 31, 2026, 05:31 PM

CDT Equity Acquires 4.76% Stake in Sarborg Limited

AI Summary

CDT Equity Inc. entered into a Securities Purchase Agreement to acquire approximately 4.76% of Sarborg Limited's outstanding common stock from certain investors. The consideration for this acquisition consists of Pre-Funded Warrants, which allow the purchase of up to 12,131,770 shares of CDT Equity's common stock at an exercise price of $0.0001 per share, pending stockholder approval for exercise beyond a certain threshold. Additionally, the company issued 123,537 common shares to four service providers for services rendered.

Key Highlights

  • CDT Equity Inc. acquired 270 shares of Sarborg Limited, representing approximately 4.76% of its outstanding common stock.
  • Consideration for the Sarborg shares included Pre-Funded Warrants to purchase up to 12,131,770 common shares.
  • The Pre-Funded Warrants have an exercise price of $0.0001 per share.
  • Stockholder approval is required for the exercise of warrants exceeding 19.99% of CDT Equity's common stock.
  • Andrew Regan's investment company, Corvus Capital Limited, received warrants for 5,436,830 shares.
  • CDT Equity also issued 123,537 common shares to four service providers on July 30 and 31, 2026.